The GenMark ePlex®: Another weapon in the syndromic arsenal for infection diagnosis Journal Article


Authors: Schmitz, J. E.; Tang, Y. W.
Article Title: The GenMark ePlex®: Another weapon in the syndromic arsenal for infection diagnosis
Abstract: As one of the most recent additions to the syndromic testing landscape, the ePlex® platform by GenMark Diagnostics is a system that combines the manufacturer's signature electrochemical detection technology with updated microfluidics, providing a new option for multiplex testing that is both rapid and requires minimal hands-on steps. In this review, we detail the ePlex platform and its current/future syndromic panels, with a particular focus on the respiratory pathogen panel - the platform's first assay to undergo clinical trials and receive regulatory approval in the USA. By keeping informed of these ever-expanding laboratory options, clinicians and microbiologists can stay positioned at the forefront of infectious disease diagnosis. © 2018 2018 Future Medicine Ltd.
Keywords: eplex; genmark; multiplex molecular testing; respiratory pathogen panel; syndromic infection testing
Journal Title: Future Microbiology
Volume: 13
Issue: 16
ISSN: 1746-0913
Publisher: Future Medicine  
Date Published: 2018-12-01
Start Page: 1697
End Page: 1708
Language: English
DOI: 10.2217/fmb-2018-0258
PROVIDER: scopus
PUBMED: 30547684
PMCID: PMC6439521
DOI/URL:
Notes: Export Date: 1 February 2019 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Yi-Wei Tang
    188 Tang